Taking on the editorship of Palliative Medicine has been an enormously interesting and challenging task. Managing the delivery of one of the foremost international academic journals in the field of palliative medicine has brought issues of responsibility at different levels. Are the published papers clinically relevant? Does the journal have multidisciplinary and international appeal? Are the research findings up to date, evidence based and methodologically sound? These and other concerns guide the content of what we seek to publish in the journal, but equally important is the responsibility that we have to authors to manage the process of submission, peer review and feedback in a timely and dependable manner. The success of a journal depends on its authors for its content and on its readership for its dissemination. The process of attracting high quality research and presenting it to an engaged readership is quite an undertaking, but it is one that we are endeavouring to carry out with efficiency and transparency.
We are using this editorial to report on the way we have managed submissions over the first year of our editorship (April 2002¡/March 2003 ; seeking to explain to readers the pathways that are followed once a manuscript has been received by the editorial office. We will be revisiting this regularly in the future, hopefully to report year on year improvements in our performance! Palliative Medicine is published in eight issues per year. Each issue is composed of a mixture of commissioned pieces, regular features, letters and original (unsolicited) papers (research findings, reviews, case reports). There are about eight original papers in each issue depending on their length and other material. This means that around 64 noncommissioned papers are published each year.
Once a paper has been submitted to the editorial office it is read by at least four members of the editorial board as to its suitability for publication. Among the criteria that are used to judge the paper are its relevance to the international field of palliative medicine, its originality and its methodological robustness. Following this initial screening process, a decision is made whether to send the paper for peer review or not. Occasionally, authors may be asked to shorten their papers and resubmit them as letters to the editor. Over the first year of current editorship, 59% of all submissions were sent on for peer review.
Each paper for review is assessed by at least two reviewers, chosen from a database of nearly 300 specialists in palliative medicine across the world. Currently, around 56% of papers are accepted for publication following peer review; most are accepted subject to minor or major revisions. Just over half of the accepted papers are subsequently published. A surprising proportion of authors decide not to revise and resubmit their papers following provisional acceptance. Overall, 20% of all papers submitted to the Journal are published.
A target of the new editorial team has been to ensure that authors are kept well informed about the progress of their papers and that decisions are made as quickly as possible. On average, authors are now informed whether the paper is being sent for peer review or not within five to six weeks. We are working to reduce this time to four weeks and less. Following notification of the paper being sent for review, authors are informed about the outcome on average within 12 weeks, which meets our current standard. The four weeks and 12 weeks standards were those we set out in our first editorial (Palliative Medicine 2003; 17: 1 ¡/2) and it is gratifying to be able to report that we are more or less on target. The length of time from first submission of the manuscript to publication date is still longer than we would like, but is currently just within a year (average is 50 weeks, with a range of 30¡/71 weeks).
Palliative Medicine aims to be an international journal with papers from research groups and individuals from all over the world. At present, most submissions come from English-speaking countries (68% of submissions), and of these, nearly three-quarters are from the UK (48% of total submissions). Increasing the proportion of papers submitted from English-speaking countries other than the UK, and from non-English-speaking countries is an important objective over coming years in order to share research findings worldwide. Our special themed issue on Euthanasia (17:2) was exceptional in the breadth of its coverage, with 55 commentaries from 32 countries. This kind of representation goes someway towards making this a truly international journal with interna-tional relevance. Again, however, we are seeking to increase the number of our non-UK peer reviewers from the relatively low proportion of 28%.
There is always more that we can do to improve the publication performance of Palliative Medicine, but we cannot do it without your support. We need your research reports and your reviews, and even if you do not have a paper to publish there are other ways of contributing. We have expanded the letters section in the Journal to provide an opportunity for your observations, statements, views and opinions. This is your forum to discuss with the international readership the issues that you think are important and can include results from small surveys or series of observations, which would otherwise not be published.
The 'impact factor' is an important measure for any peer-reviewed journal because it is so widely used as an indicator of academic performance of authors. The validity and reliability of the impact factor when used in this way remains debatable. However, it is an important target for us, and next year's rating will reflect the papers published in 2003. We look forward to seeing a significant change when we report back to you in a year's time.
The new editors have very much enjoyed taking on this task and are working well together. The impressive performance in terms of efficiency reported above owes much to the work of Debbie Ashby, who manages the Editorial Office and the Editors. Many of you will have been in touch with her and will know from first hand experience that she is a key person in running the office. We acknowledge and are grateful to Debbie for her major contribution to Palliative Medicine.
We have plans for some further innovations which we will unveil in due course. We aim to be always moving forward and hope you will want to move with us.
Margaret Robbins and Geoffrey Hanks On behalf of the Editors

